Neumora Therapeutics Shares Are Trading Higher. B of A Securities Maintained a Buy Rating on the Stock.
B of A Securities Maintains Buy on Neumora Therapeutics, Lowers Price Target to $7
Analysts Conflicted on These Healthcare Names: Neumora Therapeutics, Inc. (NMRA) and Idexx Laboratories (IDXX)
Trending Stocks as Wall Street Steps Into First Days of 2025 With Cautiousness
Sector Update: Health Care Stocks Higher Friday Afternoon
Neumora Therapeutics Up Over 16%, on Pace for Largest Percent Increase Since December 2023 -- Data Talk
blessings u : I would be very happy if it were five percent every day!
Trytosaveabit OP blessings u : I’m always happy with anything above 10%! I was board and being a bit of a smartarse because when I crashed I said it could be a great opportunity to buy! I caught some grief from some. Hehehe
blessings u Trytosaveabit OP : I am working hard to avoid drawdowns, and I am also working hard to learn how to Sell.
Trytosaveabit OP blessings u : Yes! Securing profits seems to be tough for a lot of people. But i encourage securing profits on the way up!
blessings u Trytosaveabit OP : Thank you for sharing your experience, I am now quitting greed. I wanted to sell at a high stock price too much, but ended up losing money instead.
View more comments...